Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
SYRS

Syros Pharmaceuticals

$11.96

(0.00%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
Syros Pharmaceuticals management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

Tuesday
SYRS

Syros Pharmaceuticals

$11.96

-0.41 (-3.31%)

05:54
05/22/18
05/22
05:54
05/22/18
05:54
Conference/Events
Syros Pharmaceuticals management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

Over a week ago
SYRS

Syros Pharmaceuticals

$12.50

-0.06 (-0.48%)

17:06
05/16/18
05/16
17:06
05/16/18
17:06
Hot Stocks
Syros sees opening the expansion phase of SY-1365 study in mid-2018 »

Syros Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

SYRS

Syros Pharmaceuticals

$12.16

0.27 (2.27%)

07:36
05/10/18
05/10
07:36
05/10/18
07:36
Hot Stocks
Syros says cash, cash equivalents 'sufficent' to fund operations into 2020 »

Based on its current…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

  • 23

    May

SYRS

Syros Pharmaceuticals

$12.16

0.27 (2.27%)

07:35
05/10/18
05/10
07:35
05/10/18
07:35
Earnings
Syros Pharmaceuticals reports Q1 EPS (48c), consensus (39c) »

Cash, cash equivalents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

  • 23

    May

SYRS

Syros Pharmaceuticals

$12.50

0.31 (2.54%)

04:55
05/03/18
05/03
04:55
05/03/18
04:55
Conference/Events
Syros Pharmaceuticals management to meet with Piper Jaffray »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 23

    May

SYRS

Syros Pharmaceuticals

$12.19

-0.02 (-0.16%)

04:55
05/02/18
05/02
04:55
05/02/18
04:55
Conference/Events
Syros Pharmaceuticals management to meet with Piper Jaffray »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 23

    May

SYRS

Syros Pharmaceuticals

$12.05

-0.16 (-1.31%)

10:24
05/01/18
05/01
10:24
05/01/18
10:24
Conference/Events
Syros Pharmaceuticals management to meet with Piper Jaffray »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 23

    May

Over a month ago
SYRS

Syros Pharmaceuticals

$12.60

-0.47 (-3.60%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
Syros Pharmaceuticals management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 23

    May

SYRS

Syros Pharmaceuticals

$13.07

-0.58 (-4.25%)

08:47
04/20/18
04/20
08:47
04/20/18
08:47
Conference/Events
Syros Pharmaceuticals management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 23

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.